Suppr超能文献

Cdk4(R24C)突变的种系传递促进肿瘤发生并使细胞逃脱衰老。

Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.

作者信息

Rane Sushil G, Cosenza Stephen C, Mettus Richard V, Reddy E Premkumar

机构信息

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.

出版信息

Mol Cell Biol. 2002 Jan;22(2):644-56. doi: 10.1128/MCB.22.2.644-656.2002.

Abstract

Mutations in CDK4 and its key kinase inhibitor p16(INK4a) have been implicated in the genesis and progression of familial human melanoma. The importance of the CDK4 locus in human cancer first became evident following the identification of a germ line CDK4-Arg24Cys (R24C) mutation, which abolishes the ability of CDK4 to bind to p16(INK4a). To determine the role of the Cdk4(R24C) germ line mutation in the genesis of other cancer types, we introduced the R24C mutation in the Cdk4 locus of mice by using Cre-loxP-mediated "knock-in" technology. Cdk4(R24C/R24C) mouse embryo fibroblasts (MEFs) displayed increased Cdk4 kinase activity resulting in hyperphosphorylation of all three members of the Rb family, pRb, p107, and p130. MEFs derived from Cdk4(R24C/R24C) mice displayed decreased doubling times, escape from replicative senescence, and escape sensitivity to contact-induced growth arrest. These MEFs also exhibited a high degree of susceptibility to oncogene-induced transformation, suggesting that the Cdk4(R24C) mutation can serve as a primary event in the progression towards a fully transformed phenotype. In agreement with the in vitro data, homozygous Cdk4(R24C/R24C) mice developed tumors of various etiology within 8 to 10 months of their life span. The majority of these tumors were found in the pancreas, pituitary, brain, mammary tissue, and skin. In addition, Cdk4(R24C/R24C) mice showed extraordinary susceptibility to carcinogens and developed papillomas within the first 8 to 10 weeks following cutaneous application of the carcinogens 9,10-di-methyl-1,2-benz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA). This report formally establishes that the activation of Cdk4 is sufficient to promote cancer in many tissues. The observation that a wide variety of tumors develop in mice harboring the Cdk4(R24C) mutation offers a genetic proof that Cdk4 activation may constitute a central event in the genesis of many types of cancers in addition to melanoma.

摘要

细胞周期蛋白依赖性激酶4(CDK4)及其关键激酶抑制剂p16(INK4a)的突变与家族性人类黑色素瘤的发生和发展有关。在鉴定出一种种系CDK4-Arg24Cys(R24C)突变后,CDK4基因座在人类癌症中的重要性首次变得明显,该突变消除了CDK4与p16(INK4a)结合的能力。为了确定Cdk4(R24C)种系突变在其他癌症类型发生中的作用,我们使用Cre-loxP介导的“敲入”技术将R24C突变引入小鼠的Cdk4基因座。Cdk4(R24C/R24C)小鼠胚胎成纤维细胞(MEF)显示出Cdk4激酶活性增加,导致Rb家族的所有三个成员pRb、p107和p130过度磷酸化。来自Cdk4(R24C/R24C)小鼠的MEF显示出加倍时间缩短、逃避复制性衰老以及对接触诱导的生长停滞的逃避敏感性。这些MEF还表现出对癌基因诱导的转化高度敏感,这表明Cdk4(R24C)突变可能是向完全转化表型进展的主要事件。与体外数据一致,纯合Cdk4(R24C/R24C)小鼠在其寿命的8至10个月内发生了各种病因的肿瘤。这些肿瘤大多数发生在胰腺、垂体、脑、乳腺组织和皮肤中。此外,Cdk4(R24C/R24C)小鼠对致癌物表现出非凡的敏感性,并在皮肤应用致癌物9,10-二甲基-1,2-苯并[a]蒽(DMBA)和12-O-十四烷酰佛波醇-13-乙酸酯(TPA)后的前8至10周内发生乳头瘤。本报告正式确定Cdk4的激活足以在许多组织中促进癌症。携带Cdk4(R24C)突变的小鼠发生多种肿瘤的观察结果提供了遗传学证据,表明Cdk4激活除了在黑色素瘤中之外,可能是许多类型癌症发生的核心事件。

相似文献

2
Cooperativity of Cdk4R24C and Ras in melanoma development.
Cell Cycle. 2010 Aug 15;9(16):3305-14. doi: 10.4161/cc.9.16.12632. Epub 2010 Aug 10.
3
Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice.
Cancer Res. 2006 Mar 15;66(6):2946-52. doi: 10.1158/0008-5472.CAN-05-3196.
4
Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
EMBO J. 2001 Dec 3;20(23):6637-47. doi: 10.1093/emboj/20.23.6637.
8
Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors.
Int J Hematol. 2003 Apr;77(3):259-62. doi: 10.1007/BF02983783.
9
Increased angiogenesis in Cdk4(R24C/R24C):Apc(+/Min) intestinal tumors.
Cell Cycle. 2010 Jun 15;9(12):2456-63. doi: 10.4161/cc.9.12.12055.

引用本文的文献

1
Oncogene-Induced Senescence Transcriptomes Signify Premalignant Colorectal Adenomas.
Curr Issues Mol Biol. 2025 Mar 25;47(4):221. doi: 10.3390/cimb47040221.
3
loss-of-function mutations cause microcephaly and short stature.
Genes Dev. 2025 May 2;39(9-10):634-651. doi: 10.1101/gad.352311.124.
5
Cellular senescence: Neither irreversible nor reversible.
J Exp Med. 2024 Apr 1;221(4). doi: 10.1084/jem.20232136. Epub 2024 Feb 22.
6
Cyclers' kinases in cell division: from molecules to cancer therapy.
Cell Death Differ. 2023 Sep;30(9):2035-2052. doi: 10.1038/s41418-023-01196-z. Epub 2023 Jul 29.
8
A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profiling.
J Hum Genet. 2023 May;68(5):359-361. doi: 10.1038/s10038-022-01110-4. Epub 2023 Jan 11.
9
CDK4: a master regulator of the cell cycle and its role in cancer.
Genes Cancer. 2022 Aug 25;13:21-45. doi: 10.18632/genesandcancer.221. eCollection 2022.
10
Senescence and cancer - role and therapeutic opportunities.
Nat Rev Clin Oncol. 2022 Oct;19(10):619-636. doi: 10.1038/s41571-022-00668-4. Epub 2022 Aug 31.

本文引用的文献

2
The serial cultivation of human diploid cell strains.
Exp Cell Res. 1961 Dec;25:585-621. doi: 10.1016/0014-4827(61)90192-6.
5
p53: death star.
Cell. 2000 Nov 22;103(5):691-4. doi: 10.1016/s0092-8674(00)00171-9.
7
Cellular senescence: mitotic clock or culture shock?
Cell. 2000 Aug 18;102(4):407-10. doi: 10.1016/s0092-8674(00)00046-5.
8
The Pezcoller lecture: cancer cell cycles revisited.
Cancer Res. 2000 Jul 15;60(14):3689-95.
10
Cancer, aging and cellular senescence.
In Vivo. 2000 Jan-Feb;14(1):183-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验